Blog

Stefano Arcangeli: Our one-shot single-session radiotherapy for UIR and HR PCa is finally out on IJROBP – The Red Journal

Photo of Stefano Arcangeli from micropos.se

Jul 8, 2024, 08:55

Stefano Arcangeli: Our one-shot single-session radiotherapy for UIR and HR PCa is finally out on IJROBP – The Red Journal

Valeria Faccenda, Medical Physicist at IRCCS San Gerardo dei Tintori Foundation, shared a post by Stefano Arcangeli, Radiation Oncologist and Associate Professor at the University of Milan-Bicocca, on X, adding:

”Encouraging preliminary results from ABRUPT trial on 24Gy single fraction radiotherapy to the prostate gland with urethra sparing and organ motion control! Check it out.”

Quoting Stefano Arcangeli’s post:

”Our paper on one-shot single-session radiotherapy for Unfavorable Intermediate-Risk (UIR) and High-Risk (HR) Prostate Cancer (PCa) is finally out on IJROBP – The Red Journal.

Kudos to the authors for the team effort!”

Source: Valeria Faccenda/X and Stefano Arcangeli/X

cancer cancer trial IJROBP - The Red Journal IRCCS San Gerardo dei Tintori Foundation OncoDaily Oncology Stefano Arcangeli University of Milan-Bicocca Valeria Faccenda

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage